SCHEMBL4847749

SCHEMBL4847749

Cc1cc(C)cc(-c2ccc(OCCN(C)C)c(C=CC(=O)c3ccc(NCCN(C)C)cc3)c2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 3/20 0.42
BCHE P06276 2/20 0.42
SYK P43405 2/20 0.42
MCHR1 Q99705 1/20 0.41
TNFRSF1A P19438 5/20 0.40
KDR P35968 2/20 0.39
LMNA P02545 4/20 0.39
CYP1A2 P05177 1/20 0.39
MAOA P21397 1/20 0.39
CNR1 P21554 1/20 0.39
DRD4 P21917 1/20 0.39
HRH2 P25021 1/20 0.39
HTR2A P28223 1/20 0.39
HTR2C P28335 1/20 0.39
MAPK1 P28482 1/20 0.39
NTSR1 P30989 1/20 0.39
HRH1 P35367 1/20 0.39
DRD3 P35462 1/20 0.39
SCN1A P35498 1/20 0.39
HTR2B P41595 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4852888 0.90 HCRTR2 (0.42) ACHEBCHESYKMCHR1TNFRSF1A
SCHEMBL4853801 0.90 MCHR1 (0.53) ACHEBCHEMCHR1TNFRSF1AKDR
SCHEMBL4856242 0.88 BCHE (0.45) ACHEBCHESYKTNFRSF1ALMNA
SCHEMBL4852218 0.87 CAPN1 (0.50) ACHEBCHETNFRSF1ALMNAMAOA
SCHEMBL4849986 0.87 BCHE (0.46) ACHEBCHETNFRSF1A
SCHEMBL14280884 0.87 BCHE (0.46) ACHEBCHETNFRSF1A
SCHEMBL4849921 0.86 BCHE (0.45) ACHEBCHESYKTNFRSF1ALMNA
SCHEMBL4853736 0.86 BCHE (0.52) ACHEBCHEMCHR1TNFRSF1ALMNA
SCHEMBL6386830 0.85 ABCG2 (0.52) ACHEBCHETNFRSF1ALMNAMAOA
SCHEMBL4847745 0.84 SYK (0.47) ACHEBCHESYKMCHR1TNFRSF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US claimed
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed